188 related articles for article (PubMed ID: 8325028)
1. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy.
Mestecky J; Tomana M; Crowley-Nowick PA; Moldoveanu Z; Julian BA; Jackson S
Contrib Nephrol; 1993; 104():172-82. PubMed ID: 8325028
[No Abstract] [Full Text] [Related]
2. O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role.
Hiki Y; Horii A; Iwase H; Tanaka A; Toda Y; Hotta K; Kobayashi Y
Contrib Nephrol; 1995; 111():73-84. PubMed ID: 7758349
[No Abstract] [Full Text] [Related]
3. Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1.
Mestecky J; Hashim OH; Tomana M
Contrib Nephrol; 1995; 111():66-71; discussion 71-2. PubMed ID: 7758348
[No Abstract] [Full Text] [Related]
4. Characterization of IgA1, IgA2 and secretory IgA carbohydrate chains using plant lectins.
Wold AE; Motas C; Svanborg C; Hanson LA; Mestecky J
Adv Exp Med Biol; 1995; 371A():585-9. PubMed ID: 8525995
[No Abstract] [Full Text] [Related]
5. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy.
Allen AC; Harper SJ; Feehally J
Clin Exp Immunol; 1995 Jun; 100(3):470-4. PubMed ID: 7774058
[TBL] [Abstract][Full Text] [Related]
6. Aberrant glycosylation in IgA nephropathy (IgAN).
Coppo R; Amore A
Kidney Int; 2004 May; 65(5):1544-7. PubMed ID: 15086888
[TBL] [Abstract][Full Text] [Related]
7. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
Horie A; Hiki Y; Odani H; Yasuda Y; Takahashi M; Kato M; Iwase H; Kobayashi Y; Nakashima I; Maeda K
Am J Kidney Dis; 2003 Sep; 42(3):486-96. PubMed ID: 12955676
[TBL] [Abstract][Full Text] [Related]
8. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
Xie L; Wang L; Huang J; Fan J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):227-30. PubMed ID: 20337060
[TBL] [Abstract][Full Text] [Related]
9. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis.
Allen AC; Willis FR; Beattie TJ; Feehally J
Nephrol Dial Transplant; 1998 Apr; 13(4):930-4. PubMed ID: 9568852
[TBL] [Abstract][Full Text] [Related]
10. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.
Moore JS; Kulhavy R; Tomana M; Moldoveanu Z; Suzuki H; Brown R; Hall S; Kilian M; Poulsen K; Mestecky J; Julian BA; Novak J
Mol Immunol; 2007 Apr; 44(10):2598-604. PubMed ID: 17275907
[TBL] [Abstract][Full Text] [Related]
11. Structural features of IgA molecules which contribute to IgA nephropathy.
Feehally J; Allen AC
J Nephrol; 1999; 12(2):59-65. PubMed ID: 10378660
[TBL] [Abstract][Full Text] [Related]
12. Aberrant glycosylation of IgA from patients with IgA nephropathy.
Baharaki D; Dueymes M; Perrichot R; Basset C; Le Corre R; Clèdes J; Youinou P
Glycoconj J; 1996 Aug; 13(4):505-11. PubMed ID: 8872105
[TBL] [Abstract][Full Text] [Related]
13. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
14. The interaction of selective plant lectins with neuraminidase-treated and untreated IgA1 from the sera of IgA nephropathy patients.
Hashim OH; Shuib AS; Chua CT
Immunol Invest; 2001 Feb; 30(1):21-31. PubMed ID: 11419909
[TBL] [Abstract][Full Text] [Related]
15. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
16. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.
Allen AC; Bailey EM; Barratt J; Buck KS; Feehally J
J Am Soc Nephrol; 1999 Aug; 10(8):1763-71. PubMed ID: 10446944
[TBL] [Abstract][Full Text] [Related]
17. Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains.
Hashim OH; Shuib AS; Chua CT
Nephron; 2001 Dec; 89(4):422-5. PubMed ID: 11721160
[TBL] [Abstract][Full Text] [Related]
18. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy.
Hiki Y; Kokubo T; Iwase H; Masaki Y; Sano T; Tanaka A; Toma K; Hotta K; Kobayashi Y
J Am Soc Nephrol; 1999 Apr; 10(4):760-9. PubMed ID: 10203360
[TBL] [Abstract][Full Text] [Related]
19. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
Hiki Y; Ito A; Yamamoto Y; Yamamoto K; Iwase H
Adv Otorhinolaryngol; 2011; 72():68-70. PubMed ID: 21865693
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.
Leung JC; Chan LY; Tang SC; Tam PC; Fenn J; Lai KN
Nephron Exp Nephrol; 2007; 107(3):e107-18. PubMed ID: 17957128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
